These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7374883)

  • 1. Differential effects of benztropine and desipramine on the high affinity uptake of paratyramine in slices of the caudate nucleus and hypothalamus.
    Petrali EH
    Neurochem Res; 1980 Mar; 5(3):297-300. PubMed ID: 7374883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uptake of para-tyramine and meta-tyramine into slices of the caudate nucleus and hypothalamus of the rat.
    Petrali EH; Boulton AA; Dyck LE
    Neurochem Res; 1979 Oct; 4(5):633-42. PubMed ID: 492450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo activation by benzotropine of dopamine release and synthesis in the caudate nucleus.
    Cheramy A; Gauchy G; Glowinski J; Besson MJ
    Eur J Pharmacol; 1973 Feb; 21(2):246-8. PubMed ID: 4696107
    [No Abstract]   [Full Text] [Related]  

  • 4. Benztropine-induced release of dopamine from brain in vivo.
    Goodale DB; Moore KE
    Neuropharmacology; 1975 Aug; 14(8):585-9. PubMed ID: 1178116
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of desmethylimipramine and cocaine on the uptake, retention and metabolism of H3-tyramine in rat brain slices.
    Steinberg MI; Smith CB
    J Pharmacol Exp Ther; 1970 May; 173(1):176-92. PubMed ID: 4909902
    [No Abstract]   [Full Text] [Related]  

  • 6. Reduced metabolism and turnover rates of rat brain dopamine, norepinephrine and serotonin by chronic desipramine and zimelidine treatments.
    Karoum F; Korpi ER; Linnoila M; Chuang LW; Wyatt RJ
    Eur J Pharmacol; 1984 Apr; 100(2):137-44. PubMed ID: 6234178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of reserpine and 6-hydroxydopamine on the concentrations of some arylakylamines in rat brain.
    Boulton AA; Juorio AV; Philips SR; Wu PH
    Br J Pharmacol; 1977 Jan; 59(1):209-14. PubMed ID: 837000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo effects of benztropine and nomifensine on dopamine and noradrenaline terminals in rat brain.
    Broch OJ
    Eur J Pharmacol; 1979 Oct; 58(4):419-24. PubMed ID: 510376
    [No Abstract]   [Full Text] [Related]  

  • 9. A comparison of the effects of methylphenidate and amphetamine on the simultaneous release of radiolabelled dopamine and p- or m-tyramine from rat striatal slices.
    Dyck LE; Boulton AA; Jones RS
    Eur J Pharmacol; 1980 Nov; 68(1):33-40. PubMed ID: 7449832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behavioural and biochemical comparison of amphetamine derivatives, cocaine, benztropine and tricyclic anti-depressant drugs.
    Scheel-Krüger J
    Eur J Pharmacol; 1972 Apr; 18(1):63-73. PubMed ID: 5031275
    [No Abstract]   [Full Text] [Related]  

  • 11. Release of radiolabeled dopamine, p-tyramine, and m-tyramine from rat striatal slices by some aminotetralins.
    Dyck LE
    Neurochem Res; 1981 Apr; 6(4):365-75. PubMed ID: 7266745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of selectivity between the uptake of [3H]adrenaline and [3H]noradrenaline into rat hypothalamic slices.
    Routledge C; Marsden CA
    J Neurochem; 1987 Sep; 49(3):821-7. PubMed ID: 3497226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A quantitative comparison on the effects of benztropine, cocaine and nomifensine on electrically evoked dopamine overflow and rate of re-uptake in the caudate putamen and nucleus accumbens in the rat brain slice.
    Wieczorek WJ; Kruk ZL
    Brain Res; 1994 Sep; 657(1-2):42-50. PubMed ID: 7820642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benztropine-induced prolongation of responses to vasodilator nerve stimulation in the canine paw pad.
    Bell C
    Br J Pharmacol; 1982 Jun; 76(2):231-3. PubMed ID: 7093584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of L-DOPA on the synthesis and excretion of tyramine.
    Boulton AA; Wu PH
    Adv Neurol; 1974; 5():119-25. PubMed ID: 4613157
    [No Abstract]   [Full Text] [Related]  

  • 16. Presence of dopaminergic terminals and absence of dopaminergic cell bodies in the cerebral cortex of the cat.
    Thierry AM; Hirsch JC; Tassin JP; Blanc G; Glowinski J
    Brain Res; 1974 Oct; 79(1):77-88. PubMed ID: 4425954
    [No Abstract]   [Full Text] [Related]  

  • 17. Release of biogenic amines from isolated nerve endings.
    Raiteri M; Bertollini A; del Carmine R; Levi G
    Adv Exp Med Biol; 1976; 69():319-35. PubMed ID: 941741
    [No Abstract]   [Full Text] [Related]  

  • 18. Distribution of catecholamine uptake sites in human brain as determined by quantitative [3H] mazindol autoradiography.
    Donnan GA; Kaczmarczyk SJ; Paxinos G; Chilco PJ; Kalnins RM; Woodhouse DG; Mendelsohn FA
    J Comp Neurol; 1991 Feb; 304(3):419-34. PubMed ID: 2022757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of desipramine on neuronal responses to dopamine, noradrenaline, 5-hydroxytryptamine and acetylcholine in the caudate nucleus of the rat.
    Bevan P; Bradshaw CM; Szabadi E
    Br J Pharmacol; 1975 Jul; 54(3):285-93. PubMed ID: 1164588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of high affinity dopamine uptake into the dopamine neurons of the hypothalamus.
    George SR; Van Loon GR
    Brain Res; 1982 Feb; 234(2):339-55. PubMed ID: 7059835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.